1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel prognostic model including cytogenetic and molecular data in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Goncalves, G. A. R.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia
    Meeting Abstract

    Roboz, G. J.; Sugita, M.; Mosquera, J. M.; Wilkes, D. C.; Nataraj, S.; Jimenez-Flores, R. A.; Bareja, R.; Yan, L. B.; Eng, K. W.; Croyle, J. A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • RNA binding protein RBMX is required in acute myeloid leukemia by regulating the transcriptional activity of the heterochromatin protein HP1 alpha
    Meeting Abstract

    Prieto, C.; Nguyen, D.; Vu, L. P.; Perez, A.; Gourkanti, S.; Schurer, A.; Chou, T.; Chow, A.; Taggart, J.; Barlowe, T. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation with haplo-identical CD34+ cells (haplo-dCBT) may speed neutrophil recovery although successful bridging is contingent on close haplo-winning CB unit HLA-match
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M.; Naputo, K.; Afuye, A. O.; Bhatt, V.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Multicenter microbiota analysis indicates that pre-HCT microbiota injury is prevalent across geography and predicts poor overall survival
    Meeting Abstract

    Peled, J. U.; Gomes, A. L. C.; Stein-Thoeringer, C. K.; Slingerland, J. B.; Slingerland, A. E.; Weber, D.; Markey, K. A.; Smith, M.; Ponce, D.; Clurman, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A next-generation sequencing-based karyotyping algorithm reveals the genomic structure of acute myeloid leukemia
    Meeting Abstract

    Pavlick, D.; Montesion, M.; Heerema, N. A.; Severson, E. A.; Brennan, T.; Frampton, G. M.; He, J.; Byrd, J. C.; Levine, R. L.; Burd, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Acquired resistance to BRAF inhibition in HCL is rare and retreatment with vemurafenib at relapse can induce high response rates: Final results of a phase II trial of vemurafenib in relapsed HCL
    Meeting Abstract

    Park, J. H.; Lee, J. O.; Stone, R. M.; Saven, A.; Altman, J. K.; Grever, M. R.; Rai, K. R.; Vemuri, S.; Abdel-Wahab, O. I.; Tallman, M. S.
    Blood (2018)

    Fulltext@MSK | Save
  • A phase I first-in-human clinical trial of CD19-targeted 19-28z/4-1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter's transformation
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Batlevi, C. L.; Riviere, I.; Wang, X.; Senechal, B.; Furman, R. R.; Bernal, Y.; Hall, M.; Pineda, J.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • High throughput droplet single-cell genotyping of transcriptomes (GoT) reveals the cell identity dependency of the transcriptional output of somatic mutations
    Meeting Abstract

    Nam, A. S.; Kim, K. T.; Chaligne, R.; Izzo, F.; Ang, C.; Omans, N.; Pastore, A.; Taylor, J.; Alonso, A.; Tam, W.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Combinatorial genetics uncovers novel targets for the treatment of NPM1/cohesin mutated AML
    Meeting Abstract

    Meyer, A. E.; Stelloh, C.; Fisher, J. B.; Pulakanti, K.; Vassiliou, G. S.; Viny, A. D.; Levine, R. L.; Rao, S.
    Blood (2018)

    Fulltext@MSK | Save